Validation of a model predicting enrollment status in a chemoprevention trial for breast cancer

Cancer Epidemiology Biomarkers and Prevention

Volumn 7, Issue 7, 1998, Pages 591-595

  Kinney, Anita Yeomans ^a,b,f   Vernon, Sally W ^c   Shui, Wen ^d   Weber, Diane V ^d   Schell, Michael ^a   Vogel, Victor G ^e  

^a UNIVERSITY OF NORTH CAROLINA   (United States)

^b IL   (United States)

^c UNIVERSITY OF TEXAS SCHOOL OF PUBLIC HEALTH   (United States)

^d UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^e UNIVERSITY OF PITTSBURGH CANCER INSTITUTE   (United States)

^f UNIVERSITY OF UTAH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

TAMOXIFEN;

ARTICLE; BREAST CANCER; CANCER PREVENTION; CHEMOPROPHYLAXIS; DRUG EFFICACY; ESTROGEN THERAPY; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; MAJOR CLINICAL STUDY; PREDICTION; PRIORITY JOURNAL; RISK ASSESSMENT; SCORING SYSTEM; VALIDATION PROCESS;

ANTICARCINOGENIC AGENTS; BREAST NEOPLASMS; FEMALE; HUMANS; LOGISTIC MODELS; MIDDLE AGED; PATIENT SELECTION; REPRODUCIBILITY OF RESULTS; TAMOXIFEN; TIME FACTORS;

EID: 0031903181     PISSN: 10559965     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (17)

1. Spilker, B C , and Cramer, J A Patient Recruitment in Clinical Trials. New York: Raven Press, 1992.
2. Hunninghake, D. B., Darby, C. A., and Probstfield, J. L. Recruitment experience in clinical trials literature summary and annotated bibliography Controlled Clin Trials, 8 (Suppl.): 6S-30S, 1987
3. Office of Research on Women's Health, In Recruitment, and Retention of Women in Clinical Studies. NIH Publ No. 95-3756. Bethesda, MD NIH, 1995
4. Yeomans-Kinney, A , Vernon, S. W., Frankowski, R. F., Weber, D. M., Bitsura, J. M., and Vogel, V G. Factors related to enrollment in the breast cancer prevention trial at a comprehensive cancer center during the first year of recruitment. Cancer (Phila.), 76 46-56, 1995.
5. Bush, T. L., and Helzlsouer, K. J. Tamoxifen for the primary prevention of breast cancer a review and critique of the concept and trial. Epidemiol. Rev , 15: 233-243, 1993
6. Love, R R The National Surgical Adjuvant Breast Project (NSABP) Breast Cancer Prevention Trial revisited. Cancer Epidemiol. Biomark. Prev., 2. 403-407, 1993
7. Gail, M. H., Bnnton, L. A , Byar, D. P , Corle, D. K., Green, S. B., Schairer, C , and Mulvihill, J. J. Projected individual probabilities of developing breast cancer for white females who are being examined annually J. Natl. Cancer Inst (Bethesda), 81: 1879-1886, 1989.
8. Spiegelman, D., Colditz, G. A., Hunter, D , and Hertzmark, E. Validation of the Gail et al. model for predicting individual breast cancer risk. J. Natl. Cancer Inst. (Bethesda), 86. 600-607, 1994.
9. Bondy, M. L., Lustbader, E. D., Halabi, S., Ross, E., and Vogel, V. G. Validation of a breast cancer risk assessment model in women with a positive family history. J. Natl Cancer Inst. (Bethesda), 86 620-625, 1994.
10. Rosenstock, I. M , Strecher, V. J., and Becker, M. H Social learning theory and the Health Belief Model. Health Educ. Q., 15. 175-183, 1988.
11. Fishbein, M , and Ajzen, I Belief, Attitude, Intention, and Behavior. Boston: Addison-Welsey, 1975.
12. Hudmon, K. S , and Kinney, A. Y Issues of enrollment bias in cancer chemoprevention trials. Cancer Bull , 47. 339-342, 1995.
13. SPSS Inc SPSS for Windows: Advanced Statistics, Release No 6.1. Chicago: SPSS Inc., 1994
14. StataCorp Stata Statistical Software, Release 4.0. College Station, TX: StataCorp., 1995.
15. Kleinbaum, D G., Kupper, L L., and Morgenstern, H Epidemiologie Research: Principles and Quantitative Methods. New York: Van Nostrand Reinhhold, 1987.
16. Hosmer, D. W., and Lemeshow, S Applied Logistic Regression. New York John Wiley & Sons, 1989
17. Rothert, M., Rovner, D. Holmes, M , Schmitt, N., Talarczyk, G., Kroll, J , and Gogate, J. Women's use of information regarding hormone replacement therapy Res. Nurs. Health, 13: 355-366, 1990.